Wall Street Analysts See a 76.74% Upside in Zymeworks (ZYME): Can the Stock Really Move This High?

Zymeworks Inc. (ZYME) closed the last trading session at $12.08, gaining 2.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 21.35 indicates a 76.7% upside potential.The mean estimate comprises 10 short-term price targets with a standard deviation of $7.45. While the lowest estimate of$ 12 indicates a 0.7% decline from the current price level, the most optimistic analyst expects ...